stroke

neural regeneration
Biotech

Bioxodes halts phase 2 stroke trial after interim review success

Bioxodes has stopped enrollment after hitting the safety and efficacy endpoints, positioning it to power into a potentially registrational trial.
Nick Paul Taylor Apr 24, 2025 9:32am
Brain and money connected by a thread on a white background

Stroke tech developers Kandu, Neurolutions to combine

Apr 8, 2025 2:00pm
colorful brain art model

Medtronic inks stroke AI partnership with developer Methinks

Apr 2, 2025 11:54am
brain amyloid alzheimers strings detailed web complicated thought

MicroTransponder nets $65M for stroke rehab neurostimulator

Mar 14, 2025 12:53pm
doctor examining brain mri scans

FDA clears Imperative Care's largest large-bore stroke catheter

Jan 28, 2025 4:00pm
heart

Boston Scientific, Abbott tout long-term heart occluder data

Nov 19, 2024 12:00pm